Recovery of human papillomavirus nucleic acids from liquid-based cytology media

Journal of Virological Methods

Volumn 137, Issue 1, 2006, Pages 58-62

  Powell, Ned ^a   Smith, Kelly ^b   Fiander, Alison ^a  

^a DEPARTMENT OF OBSTETRICS AND GYNAECOLOGY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Human papillomavirus; LBC; RNA; SurePath; ThinPrep

Indexed keywords

DNA; RNA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CYTOLOGY; DIAGNOSTIC PROCEDURE; DNA VIRUS; GENE EXPRESSION; HUMAN; HUMAN CELL; IMAGING SYSTEM; LIQUID CULTURE; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA VIRUS; SYSTEM ANALYSIS; UTERINE CERVIX CANCER; WART VIRUS;

CYTOLOGICAL TECHNIQUES; DNA, VIRAL; HUMANS; INDICATORS AND REAGENTS; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING;

HUMAN PAPILLOMAVIRUS;

EID: 33746907110     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2006.05.033     Document Type: Article

References (19)

1. Andersson S., Safari H., Mints M., Lewensohn-Fuchs I., Gyllensten U., and Johansson B. Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN). Br. J. Cancer 92 (2005) 2195-2200
2. Anon. Guidance on the use of liquid-based cytology for cervical screening. Technology Appraisal vol. 69 (2003), National Institute for Clinical Excellence
3. Bosch F.X., and de Sanjose S. Human papillomavirus and cervical cancer-burden and assessment of causality. J. Natl. Cancer Inst. Monogr. 31 (2003) 3-13
4. Brummer, O., Hollwitz, B., Bohmer, G., Kuhnle, H., Petry, K.U., 2006. Human papillomavirus-type persistence patterns predict the clinical outcome of cervical intraepithelial neoplasia. Gynecol. Oncol., doi:10.1016/j.ygyno.2006.01.020.
5. Cuschieri K.S., Beattie G., Hassan S., Robertson K., and Cubie H. Assessment of human papillomavirus mRNA detection over time in cervical specimens collected in liquid based cytology medium. J. Virol. Meth. 124 (2005) 211-215
6. Cuschieri K.S., Whitley M.J., and Cubie H.A. Human papillomavirus type specific DNA and RNA persistence-implications for cervical disease progression and monitoring. J. Med. Virol. 73 (2004) 65-70
7. Habis A.H., Vernon S.D., Lee D.R., Verma M., and Unger E.R. Molecular quality of exfoliated cervical cells: implications for molecular epidemiology and biomarker discovery. Cancer Epidemiol. Biomark. Prev. 13 (2004) 492-496
8. Josefsson A.M., Magnusson P.K., Ylitalo N., Sorensen P., Qwarforth-Tubbin P., Andersen P.K., Melbye M., Adami H.O., and Gyllensten U.B. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 355 (2000) 2189-2193
9. Kraus I., Molden T., Holm R., Lie A.K., Karlsen F., Kristensen G.B., and Skomedal H. Presence of e6 and e7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas. J. Clin. Microbiol. 44 (2006) 1310-1317
10. Lamarcq L., Deeds J., Ginzinger D., Perry J., Padmanabha S., and Smith-McCune K. Measurements of human papillomavirus transcripts by real time quantitative reverse transcription-polymerase chain reaction in samples collected for cervical cancer screening. J. Mol. Diagn. 4 (2002) 97-102
11. McGoogan E. Liquid-based cytology: the new screening test for cervical cancer control. J. Fam. Plann. Reprod. Health Care 30 (2004) 123-125
12. Molijn A., Kleter B., Quint W., and van Doorn L.J. Molecular diagnosis of human papillomavirus (HPV) infections. J. Clin. Virol. 32 Suppl. 1 (2005) S43-S51
13. Sambrook J., Fritsch E.F., and Maniatis T. Molecular Cloning: A Laboratory Manual (1989), Cold Spring Harbor Laboratory, NY
14. Scheurer M.E., Tortolero-Luna G., Guillaud M., Follen M., Chen Z., Dillon L.M., and Adler-Storthz K. Correlation of human papillomavirus type 16 and human papillomavirus type 18 e7 messenger RNA levels with degree of cervical dysplasia. Cancer Epidemiol. Biomark. Prev. 14 (2005) 1948-1952
15. Swan D.C., Tucker R.A., Tortolero-Luna G., Mitchell M.F., Wideroff L., Unger E.R., Nisenbaum R.A., Reeves W.C., and Icenogle J.P. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J. Clin. Microbiol. 37 (1999) 1030-1034
16. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., and Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 (1999) 12-19
17. Wang-Johanning F., Lu D.W., Wang Y., Johnson M.R., and Johanning G.L. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis. Cancer 94 (2002) 2199-2210
18. Watanabe S., Kanda T., and Yoshiike K. Human papillomavirus type 16 transformation of primary human embryonic fibroblasts requires expression of open reading frames E6 and E7. J. Virol. 63 (1989) 965-969
19. zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184 (1991) 9-13